EP3846787A4 - NEW COMPOSITION OF LAPATINIB IN SOLID ORAL GALENIC FORM AND METHOD OF MANUFACTURING - Google Patents

NEW COMPOSITION OF LAPATINIB IN SOLID ORAL GALENIC FORM AND METHOD OF MANUFACTURING Download PDF

Info

Publication number
EP3846787A4
EP3846787A4 EP19857473.3A EP19857473A EP3846787A4 EP 3846787 A4 EP3846787 A4 EP 3846787A4 EP 19857473 A EP19857473 A EP 19857473A EP 3846787 A4 EP3846787 A4 EP 3846787A4
Authority
EP
European Patent Office
Prior art keywords
lapatinib
manufacturing
solid oral
new composition
galenic form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19857473.3A
Other languages
German (de)
French (fr)
Other versions
EP3846787A1 (en
Inventor
Dharmesh Mahendrabhai Shah
Aravind Manappa Badiger
Mukeshkumar Subhashchandra SHARMA
Madhavkumar Dilipbhai TRIVEDI
Harikrishnabhai Vinubhai PATEL
Prashant Karamshibhai PATEL
Prashant Kanaiyalal GANDHI
Nimitkumar Harishchandra PANCHAL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BDR Pharmaceuticals International Pvt Ltd
Original Assignee
BDR Pharmaceuticals International Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BDR Pharmaceuticals International Pvt Ltd filed Critical BDR Pharmaceuticals International Pvt Ltd
Publication of EP3846787A1 publication Critical patent/EP3846787A1/en
Publication of EP3846787A4 publication Critical patent/EP3846787A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP19857473.3A 2018-09-03 2019-08-30 NEW COMPOSITION OF LAPATINIB IN SOLID ORAL GALENIC FORM AND METHOD OF MANUFACTURING Withdrawn EP3846787A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201821032977 2018-09-03
PCT/IB2019/057324 WO2020049429A1 (en) 2018-09-03 2019-08-30 Novel composition of lapatinib of oral solid dosage form and method of manufacturing thereof

Publications (2)

Publication Number Publication Date
EP3846787A1 EP3846787A1 (en) 2021-07-14
EP3846787A4 true EP3846787A4 (en) 2022-05-25

Family

ID=69723001

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19857473.3A Withdrawn EP3846787A4 (en) 2018-09-03 2019-08-30 NEW COMPOSITION OF LAPATINIB IN SOLID ORAL GALENIC FORM AND METHOD OF MANUFACTURING

Country Status (7)

Country Link
EP (1) EP3846787A4 (en)
BR (1) BR112021004047A2 (en)
CL (1) CL2021000512A1 (en)
MX (1) MX2021002441A (en)
PH (1) PH12021550451A1 (en)
WO (1) WO2020049429A1 (en)
ZA (1) ZA202101538B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010023187A1 (en) * 2008-08-25 2010-03-04 Ratiopharm Gmbh Pharmaceutical composition comprising n-[3-chloro-4-[(3- fluorophenyl)methoxy]phenyl]-6-[5[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furyl]-4- quinazolinamine
WO2010023188A1 (en) * 2008-08-25 2010-03-04 Ratiopharm Gmbh Pharmaceutical composition comprising n-[3-chloro-4-[(3- fluorophenyl)methoxy]phenyl]-6-[5[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furyl]-4- quinazolinamine
WO2011146710A1 (en) * 2010-05-21 2011-11-24 Glaxosmithkline Llc Combination
CN106511289A (en) * 2015-09-10 2017-03-22 湖北生物医药产业技术研究院有限公司 Benzenesulfonicacid lapatinib tablets and preparing method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130131090A1 (en) * 2010-08-03 2013-05-23 Bandi Parthasaradhi Reddy Salts of lapatinib
WO2015145145A1 (en) * 2014-03-24 2015-10-01 Cipla Limited Pharmaceutical composition comprising lapatinib

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010023187A1 (en) * 2008-08-25 2010-03-04 Ratiopharm Gmbh Pharmaceutical composition comprising n-[3-chloro-4-[(3- fluorophenyl)methoxy]phenyl]-6-[5[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furyl]-4- quinazolinamine
WO2010023188A1 (en) * 2008-08-25 2010-03-04 Ratiopharm Gmbh Pharmaceutical composition comprising n-[3-chloro-4-[(3- fluorophenyl)methoxy]phenyl]-6-[5[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furyl]-4- quinazolinamine
WO2011146710A1 (en) * 2010-05-21 2011-11-24 Glaxosmithkline Llc Combination
CN106511289A (en) * 2015-09-10 2017-03-22 湖北生物医药产业技术研究院有限公司 Benzenesulfonicacid lapatinib tablets and preparing method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2020049429A1 *

Also Published As

Publication number Publication date
WO2020049429A1 (en) 2020-03-12
EP3846787A1 (en) 2021-07-14
ZA202101538B (en) 2022-07-27
BR112021004047A2 (en) 2021-05-25
CL2021000512A1 (en) 2021-11-26
PH12021550451A1 (en) 2021-09-27
MX2021002441A (en) 2021-03-25

Similar Documents

Publication Publication Date Title
EP3849568A4 (en) ORGANOID COMPOSITIONS FOR THE PRODUCTION OF HEMATOPOIETIC STEM CELLS AND THEIR DERIVATIVES
EP3905277A4 (en) SOLID ELECTROLYTE COMPOSITION AND METHOD FOR PRODUCING SOLID ELECTROLYTE ELEMENT
EP3976070A4 (en) SHAPED ORGANOID COMPOSITIONS AND METHODS FOR THEIR PRODUCTION
EP3981400A4 (en) ORAL CAPSULE AND METHOD OF MANUFACTURE THEREOF
EP3890747A4 (en) COMPOSITIONS FOR THE TREATMENT OF FIBROSIS AND INFLAMMATION
EP3604513A4 (en) COMPOSITION FOR THE PRODUCTION OF TAGATOSE AND METHOD FOR THE PRODUCTION OF TAGATOSE USING IT
EP4075557A4 (en) SOLID ELECTROLYTE COMPOSITION AND METHOD FOR MAKING SOLID ELECTROLYTE ELEMENT
EP3742228A4 (en) COMPOSITION OF PHOTOPOLYMER
EP4367198A4 (en) GEOPOLYMER COMPOSITIONS AND PROCESSES
EP3601477A4 (en) METHODS OF MANUFACTURING AND USING DELAYED ACID COMPOSITIONS FOR WELL STIMULATION
EP4056551A4 (en) CRYSTALLINE FORM I OF CURCUMIN DERIVATIVE, ITS PREPARATION METHOD AND USE
EP4516292A4 (en) INSTANT NANOPARTICLE COMPOSITION AND MANUFACTURING METHOD FOR IT
EP4442694A4 (en) NEW CRYSTALLINE FORM OF TRISACCHARIDE
EP4080742A4 (en) METHOD OF MANUFACTURING CAST ENGINE AND CAST ENGINE
EP4007701C0 (en) PASTE COMPOSITION FOR GENERATIVE MANUFACTURING
EP3853349A4 (en) METHODS FOR PRODUCING ANGIOBLASTS AND SINUSOIDAL ENDOTHELIAL-LIKE CELLS AND COMPOSITIONS THEREOF
EP4434357A4 (en) COMPOSITION AND MANUFACTURING METHOD FOR IT AND USE OF IT
EP4024682A4 (en) ENGINE AND ENGINE MANUFACTURING METHOD
EP3918925A4 (en) ARTIFICIAL HONEY COMPOSITION AND PRODUCTION PROCESS
EP3919557A4 (en) COMPOSITION OF SILICONE AND SETTING GREASE
KR102364062B9 (en) Anti-inflammatory composition containing active goat ginseng and its manufacturing method
EP3761969A4 (en) COOLING COMPOSITION AND METHOD OF USE
EP4048230C0 (en) ORAL GLIPTIN COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
EP4578905A4 (en) COMPOSITION, MANUFACTURING METHOD FOR IT AND USE OF IT
EP3426621A4 (en) CERAMIC ADDITIVE FORMULATION AND METHOD OF MANUFACTURE

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210401

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20220426

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 405/04 20060101ALI20220420BHEP

Ipc: A61K 31/517 20060101ALI20220420BHEP

Ipc: A61K 9/20 20060101AFI20220420BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20250314

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20250715